ALV Insider Filing: Yih Sng Receives Multiple RSU Grants
Rhea-AI Filing Summary
Yih Sng, President, Autoliv China and an officer of Autoliv Inc. (ALV), received multiple restricted stock unit (RSU) awards on 09/23/2025. The filings show performance-based RSUs from the 2023 grant (14.9957 RSUs acquired, resulting in 2,251.6444 RSUs beneficially owned following the transaction) and performance-based RSUs from the 2024 grant (5.0146 RSUs acquired, resulting in 641.7505 RSUs beneficially owned). In addition, four tranches of time-based restricted stock units were acquired (4.9986 RSUs with a 02/15/2026 vest/expiration date, 3.9165 RSUs with a 02/20/2027 vest/expiration date, and 4.739 RSUs with a 02/21/2028 vest/expiration date), producing post-transaction beneficial ownership totals of 750.5481, 588.0779 and 711.5822 RSUs respectively. The form notes that each RSU represents a contingent right to one share and that dividend equivalents accrue as additional RSUs. The performance-based RSUs vest contingent on specified performance periods and committee certification.
Positive
- Performance-based RSUs (2023 and 2024 grants) were recorded, which vest contingent on completion of specified performance periods and committee certification.
- Dividend equivalents accrue in the form of additional RSUs, per the award agreement.
- Each RSU converts to one share upon vesting, and the form provides post-transaction beneficial ownership totals for each award line.
Negative
- None.
Insights
TL;DR: Officer equity awards were recorded; disclosure shows performance and time‑based RSUs and resulting beneficial ownership totals.
The Form 4 documents equity compensation activity for an executive officer rather than a market-moving sale or purchase of open‑market shares. The filing lists both performance-based and time-based restricted stock units received on 09/23/2025 and shows the post-transaction beneficial ownership amounts for each award line. The performance-based awards reference multi-year performance periods and committee certification for vesting; dividend equivalents accrue as additional RSUs per the award agreement. There are no cash proceeds or exercise prices reported because these are RSUs (price shown as $0). From an investor perspective, this is a routine insider compensation disclosure reflecting incentive alignment rather than a liquidity event.
TL;DR: Governance disclosure indicates structured, performance-tied equity grants with documented vesting mechanics and dividend-equivalent treatment.
The Form 4 details that performance-based RSUs (2023 and 2024 grants) vest after completion of defined one-year performance periods and require certification by the Leadership Development and Compensation Committee. The explanation confirms dividend equivalents are paid as additional RSUs and that each RSU converts to one share upon vesting. Time-based RSU tranches include explicit exercisable/expiration dates for conversion. The disclosure is consistent with standard executive equity compensation and provides clear mechanics for how and when these awards may convert into shares.